Shazia Bhombal

Shazia Bhombal

Auto-generated profile, based on publicly available information

Shazia Bhombal

Division of Neonatology, Emroy School of Medicine, Childrens’s Healthcare of Atlanta, 2220 North Druid Hills Rd, Atlanta, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
CBCarl H. Backes
Carl H. Backes
KHKevin D. Hill
Kevin D. Hill
ESElaine L. Shelton
Elaine L. Shelton
JSJonathan L. Slaughter
Jonathan L. Slaughter
TLTamorah Lewis
Tamorah Lewis
VGVidu Garg
Vidu Garg
The burden of patent ductus arteriosus (PDA) continues to be significant. In view of marked differences in preterm infants versus more mature, term counterparts (viewed on a continuum with adolescent and adult patients), mechanisms regulating ductal patency, genetic contributions, clinical consequences, and diagnostic and treatment thresholds are discussed separately, when appropriate. Among both preterm infants and older children and adults, a range of hemodynamic profiles highlighting the markedly variable consequences of the PDA are provided. In most contemporary settings, transcatheter closure is preferable over surgical ligation, but data on longer‐term outcomes, particularly among preterm infants, are lacking. The present review provides recommendations to identify gaps in PDA diagnosis, management, and treatment on which subsequent research can be developed. Ultimately, the combination of refined diagnostic thresholds and expanded treatment options provides the best opportunities to address the burden of PDA. Although fundamental gaps remain unanswered, the present review provides pediatric and adult cardiac care providers with a contemporary framework in PDA care to support the practice of evidence‐based medicine.

1 January 2019 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
MSMeera N. Sankar
Meera N. Sankar
SBShazia Bhombal
Shazia Bhombal
WBWilliam E Benitz
William E Benitz
Management of patent ductus arteriosus in extremely preterm infants remains a topic of debate. Treatment to produce ductal closure was widely practiced until the past decade, despite lack of evidence that it decreases morbidities or mortality. Meta‐analyses of trials using nonsteroidal anti‐inflammatory drugs have shown effectiveness in accelerating ductal closure, but no reduction in neonatal morbidities, regardless of agent used, indication, timing, gestational age, or route of administration. Surgical ligation closes the ductus but is associated with adverse effects. Recent experience with conservative approaches to treatment suggest improved neonatal outcomes and a high rate of spontaneous ductal closure after discharge. Careful postdischarge follow‐up is important, however, because potential adverse effects of long‐standing aortopulmonary shunts may be an indication for catheter‐based ductal closure. Identification of extremely preterm infants at greatest risk of potential harm from a persistently patent ductus, who may benefit most from treatment are urgently needed.

11 August 2022 in Seminars in Fetal and Neonatal Medicine
Verified
Journal Article
Closed access
SBShazia Bhombal
Shazia Bhombal
NPNeil Patel
Neil Patel

12 December 2017 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
GAGabriel Altit
Gabriel Altit
HLHenry Lee
Henry Lee
SHSusan R Hintz
Susan R Hintz
TTTheresa A. Tacy
Theresa A. Tacy
JFJeffrey A. Feinstein
Jeffrey A. Feinstein
SBShazia Bhombal
Shazia Bhombal

12 April 2018 in Neonatology
Verified
Journal Article
Closed access
PDF file
GAGabriel Altit
Gabriel Altit
SBShazia Bhombal
Shazia Bhombal
TTTheresa A. Tacy
Theresa A. Tacy
VCValerie Y. Chock
Valerie Y. Chock
Background: For neonates with congenital heart disease (CHD), left-sided (LL) and right-sided (RL) single ventricular physiologies (LL, hypoplastic left heart syndrome; RL, tricuspid atresia or pulmonary atresia with intact ventricular septum) may demonstrate distinct changes in tissue saturation in the first 72 h of life. Near-infrared spectroscopy (NIRS) can measure regional cerebral saturation (Csat) and renal saturation (Rsat) to clarify differences between LL and RL over time. Objectives: Our primary objective was to measure changes in Csat and Rsat in the first 72 h of life using NIRS between CHD infants with LL compared to RL. The secondary objective was to correlate NIRS values to an echocardiographic marker of perfusion. Method: Newborns with hypoplastic left heart syndrome, tricuspid atresia, and pulmonary atresia with intact ventricular septum from 2013 to 2016 underwent routine NIRS monitoring. Csat, Rsat, and systemic saturations (SpO2) in the first 72 h of life were retrospectively analyzed and the echocardiographic descending aorta velocity time integral (VTI) was measured. Mixed effects models compared differences over time between LL and RL. Results: The final cohort included 13 LL, 12 RL, and 4 controls. Csat decreased for RL compared to LL (p = 0.005), while Rsat decreased for both (p = 0.008). Over time, SpO2 increased for LL but decreased for RL (p = 0.046). Compared to the controls, infants with CHD had lower Csat, lower Rsat, and lower SpO2. The descending aorta VTI was correlated with Rsat (R2 = 0.24, p = 0.02). Conclusion: NIRS Csat measures were better preserved in LL compared to RL. Rsat decreased in both groups through time. The correlation between the descending aorta VTI and Rsat suggests an association between NIRS measures of renal saturation and renal perfusion.

1 August 2025 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
MFMaría V. Fraga
María V. Fraga
SBShazia Bhombal
Shazia Bhombal
CJCourtney Juliano
Courtney Juliano
MKMinso Kim
Minso Kim
AGAlan M. Groves
Alan M. Groves
CPColin Parker
Colin Parker
Point-of-care ultrasound (POCUS) has become essential for diagnosing and managing critically ill newborns. This technology offers rapid, non-invasive assessments and supports bedside clinical decision-making. Although POCUS applications in neonatology continue to expand, there remains a lack of standardized training, certification, and credentialing processes. This paper provides expert-based perspectives and guidelines for implementing neonatal POCUS, focusing on the core components of competency, credentialing, and quality assurance (QA). Recommendations include performing a minimum number of scans for various neonatal applications, integrating competency assessments into training programs, and ensuring a robust image repository and reporting pathway. Neonatal POCUS improves patient care, and establishing clear standards and frameworks will enhance provider performance, and ensure patient safety in neonatal intensive care units (NICUs).